Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biocurrent
AddedFeb 17, 2024
UpdatedJun 18, 2026
Biocurrent

Biocurrent

Bioelectronic medicine firm led by tech prodigy and former executive, Andrew Blount.

Founded
2022
Overview
Compare
Fundraising
Employees
Website

Biocurrent, founded by tech prodigy Andrew Blount, is a bioelectronic medicine company focused on pioneering advancements in human brain wave modulation. The company's core mission is to harness the power of bioelectronic technology to improve health outcomes and enhance cognitive functions. Biocurrent offers innovative products and services designed to modulate brain activity, targeting both medical and consumer markets.

Andrew Blount, a former mayor of Laguna Hills, California, and an executive officer of a publicly traded company, leads Biocurrent. Under his leadership, the company has made significant strides in the bioelectronic medicine field. Notable investors and key achievements remain undisclosed, but Biocurrent's impact lies in its potential to revolutionize how brain-related conditions are treated and managed, positioning itself as a forward-thinking leader in the intersection of technology and medicine.

Biocurrent - Similar Companies

Boomerang Medical logo

Boomerang Medical

Motif Neurotech logo

Motif Neurotech

Bios Health logo

Bios Health

bios.health

Morphoceuticals logo

Morphoceuticals

Niche Biomedical logo

Niche Biomedical

Bionic Health logo

Bionic Health

bionichealth.com

BioHealthonomics logo

BioHealthonomics

Beta Bionics logo

Beta Bionics

BioCircuit Technologies logo

BioCircuit Technologies

biocircuit.com

Curie.Bio logo

Curie.Bio

curie.bio

Blaire Biomedical logo

Blaire Biomedical

Bioniq Health logo

Bioniq Health

Biolectrics logo

Biolectrics

Valion Bio logo

Valion Bio

tivichealth.com

Cala Health logo

Cala Health

calahealth.com

Biocurrent - Quick Facts

Who are Biocurrent's competitors?

Companies similar to Biocurrent include Boomerang Medical, Motif Neurotech, Bios Health and Morphoceuticals.

When was Biocurrent founded?

Biocurrent was founded in 2022.

When was Biocurrent's last funding round?

Biocurrent's most recent funding round was for $4M (USD) in February 2022.

How much has Biocurrent raised to-date?

As of Feb 2, 2022, Biocurrent has raised a total of $4M (USD).

How many employees does Biocurrent have?

Biocurrent has 1 employee as of Feb 4, 2024.

Biocurrent - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software